This treatment for benign prostatic hyperplasia (BPH) includes a laser treatment called holmium laser enucleation of the prostate. This treatment, explored by Dr. James Lingeman, treats both BPH and prostate cancer. Lin...
A groundbreaking research effort involving teams from the University of Virginia, Mount Sinai, the University of Michigan, the University of Texas, and others has displayed the clinical efficacy of an innovative therapy that utilizes nanoparticles and laser guidance for prostate cancer treatment. The fi...
Trial to Test Focal Laser Ablation Therapy for Localized Prostate Cancer October 15, 2020 An investigator-initiated trial soon will evaluate Clinical Laserthermia Systems’ Tranberg Thermal therapy, a focal ablation ... News New AI Algorithm Can Accurately Identify, Grade Prostate Cancer ...
Focal therapy is an emerging treatment option that involves the focal ablation of prostate cancer with preservation of surrounding healthy tissue. This approach might result in reduced morbidity when compared with whole-gland therapies. In current practice, much controversy surrounds optimal patient ...
Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer. Lasers Surg Med. 2006;38(5):356–63. Zaak D, Sroka R, Höppner M, et al. Photodynamic therapy by means of 5-ALA induced PPIX in human prostate cancer – preliminary results. Med Laser Appl. ...
ADT: androgen deprivation therapy; RP: radical prostatectomy; and RT: radiotherapy. When a patient has a low or intermediate risk of prostate cancer (life expectancy >10 years), active surveillance is the appropriate strategy, having been proven by several studies to avoid unnecessary and more agg...
Enucleative procedures. Enucleative procedures, such as holmium laser enucleation of the prostate (HoLEP), generally remove all the prostate tissue blocking urine flow and prevent regrowth of tissue. The removed tissue can be examined for prostate cancer and other conditions. These procedures are ...
Prostate cancer is a clinically heterogeneous disease that is indolent, localized, invasive, and metastatic, with multiple mechanisms and signaling pathways involved in its genesis and evolution. It could develop resistance to conventional treatment, and
Prostate cancer is comprised nearly always of adenocarcinomacells -- cells that arise from glandular tissue. Cancer cells are named according to the organ in which they originate no matter where in the body we find such cells. Thus, if prostate cancer cells spread in the body to the bones, ...
Prostate cancer is comprised nearly always of adenocarcinomacells -- cells that arise from glandular tissue. Cancer cells are named according to the organ in which they originate no matter where in the body we find such cells. Thus, if prostate cancer cells spread in the body to the bones, ...